文献速递主动脉疾病

肾下腹主动脉瘤破裂的腔内与开放修复:单中心经验

Endovascular and Open Repair of Ruptured Infrarenal Aortic Aneurysms at a Tertiary Care Center.
PubMed 文献 · Ann Vasc Surg · 2017-02-24

该回顾性研究比较了2000至2011年间一家三级中心99例肾下腹主动脉瘤破裂患者接受腔内修复(EVAR,25例)与开放修复(OR,74例)的结果。两组30天死亡率(EVAR 24.0% vs OR 39.2%,P=0.17)和1年死亡率(32.0% vs 44.6%,P=0.27)无显著差异,主要并发症率亦无差异。EVAR组失血量更少(中位数0.3 L vs 3.0 L,P<0.0001)、输血量更少(5.0 U vs 9.0 U,P=0.0041),且更多患者出院回家(66.7% vs 57.1%,P=0.03)。

要点

  • EVAR与OR在破裂腹主动脉瘤的30天和1年死亡率无显著差异。
  • EVAR组失血量和输血需求显著低于开放修复组。
  • EVAR适用于血流动力学稳定且解剖条件合适的患者。

核心结论

  • 本组破裂腹主动脉瘤患者中,EVAR与OR在死亡率和主要并发症方面无显著差异。
  • EVAR适用于稳定且解剖合适的破裂腹主动脉瘤患者。

研究设计与样本

  • 排除拒绝修复(14例)或修复前死亡(13例)者,最终99例接受修复,其中EVAR 25例(25.3%),OR 74例(74.7%)。

主要发现

  • 总体30天死亡率为35.4%,1年死亡率为41.4%。
  • 30天死亡率EVAR组24.0% vs OR组39.2%(P=0.17),1年死亡率EVAR组32.0% vs OR组44.6%(P=0.27)。
  • 主要并发症率EVAR组60.0% vs OR组60.8%(P=0.94)。
  • EVAR组失血量中位数0.3 L vs OR组3.0 L(P<0.0001),输血量中位数5.0 U vs 9.0 U(P=0.0041)。
  • EVAR组出院回家比例66.7% vs OR组57.1%(P=0.03),总住院时间中位数8.5天 vs 15天(P=0.18)。

临床怎么用

  • 对于破裂腹主动脉瘤,EVAR可作为稳定且解剖合适患者的治疗选择。
  • EVAR可减少失血和输血需求,并提高出院回家比例。

局限性

  • 回顾性单中心研究,样本量有限。
  • EVAR组样本量较小(25例),可能影响统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The mortality of ruptured abdominal aortic aneurysms (rAAAs) has been reported as high as 90%. Loss of consciousness and a systolic blood pressure of <80 mm Hg on presentation are the most important predictors of mortality after emergent open repair (OR). Endovascular repair of abdominal aortic aneurysm (EVAR) has reduced short-term operative mortality and morbidity for elective abdominal aortic aneurysm repair, and may be advocated for wider application of EVAR for rAAA. The objective of this study is to compare our experience with OR and EVAR management of rAAA. METHODS: Retrospective review of all rAAAs presenting to a tertiary care center between January 1, 2000 and December 31, 2011 was performed. Patients were grouped based on the surgical approach (OR versus EVAR). Patient demographics, intraoperative details, and postoperative mortality and morbidity rates were compared. Statistical analyses were conducted with Stata, version 12. RESULTS: One hundred twenty-six patients presented with rAAA over the study period. Patients who declined repair (n = 14) or died before repair (n = 13) were excluded from this study. Of the 99 patients who underwent repair, 25 patients (25.3%) received EVAR and 74 (74.7%) underwent OR. One patient required conversion to OR from EVAR (1.0%). Overall, 30-day and 1-year mortality was 35.4% and 41.4%, respectively, with no difference seen between the 2 types of repair (30-day mortality: EVAR = 24.0%, OR = 39.2%, P = 0.17; 1-year mortality: EVAR = 32.0%, OR = 44.6%, P = 0.27). Major morbidity also did not differ between the 2 repair procedures (EVAR = 60.0%, OR = 60.8%, P = 0.94). However, patients undergoing EVAR had significantly less estimated blood loss (median: 0.3 vs. 3.0 L, P < 0.0001) and transfusion requirement (median: 5.0 vs. 9.0 U, P = 0.0041). Furthermore, although there was no significant difference in length of overall hospital stay between the 2 groups (8.5 vs. 15 days in the OR group, P = 0.18), significantly more patients in the EVAR group were discharged to home (66.7% vs. 57.1% in the OR group, P = 0.03). CONCLUSIONS: In contrast to recently published series, this series shows no differences in morbidity or mortality between EVAR or OR of rAAAs. EVAR is appropriate in stable patients with a rAAA and favorable anatomy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Schechter MA, Pascarella L, Thomas S, et al. Endovascular and Open Repair of Ruptured Infrarenal Aortic Aneurysms at a Tertiary Care Center. Ann Vasc Surg. 2017. PMID: 28238928. doi:10.1016/j.avsg.2016.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。